1.
Jezeršek Novaković B, Kotnik V, Južnič Šetina T, Vovk M, Novaković S. Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma. Radiol Oncol [Internet]. 2007 Mar. 1 [cited 2026 Jun. 17];41(1). Available from: https://www.radioloncol.com/index.php/ro/article/view/1240